News & Updates
Showing Cardiology articles
Showing

HF drug provides 24-hour BP-lowering effect in Asians with hypertension
The angiotensin receptor neprilysin inhibitor sacubitril/valsartan, used for heart failure, appears to have potent effects on 24‐hour blood pressure (BP) in Japanese patients with mild‐to‐moderate hypertension and in the subgroup of those with nondipping BP pattern, as shown in a study.

Preop hypertension, hypercholesterolemia foretell T2DM persistence after metabolic surgery
For patients with obesity and type 2 diabetes mellitus (T2DM) who are scheduled to undergo metabolic surgery, the presence of hypertension and hypercholesterolemia at baseline may predict failure of T2DM remission after the procedure, according to a study.

Frailty may portend cognitive decline
Initial frailty status appears to be a potential predictor of the occurrence of the composite of probable dementia and mild cognitive impairment, and this association is strengthened by intensive blood pressure control, as reported in a study.

Obesity may induce RAAS activation in children
Obesity appears to play a major role in the activation of the renin‒angiotensin‒aldosterone system (RAAS), with a noticeable rise of angiotensin-converting enzyme (ACE) and ACE activities during childhood, reveals a recent study. In addition, sex differences are present in the association of ACE and ACE2 activities with blood pressure (BP).




